1 / 2

100

Supplemental figure I. A. B. C. NS. 120. 8. 0.030. 100. NS. NS. 6. NS. 80. 0.020. ##. Relative liver PPAR a mRNA expression. Liver TC (µg/µg prot). Liver weight (%). 60. 4. 0.010. 40. 2. 20. ###. +/+. +/-. -/-. +/+. +/-. -/-. +/+. +/-. -/-. PPAR a. PPAR a.

yvon
Download Presentation

100

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Supplemental figure I A B C NS 120 8 0.030 100 NS NS 6 NS 80 0.020 ## Relative liver PPARa mRNA expression Liver TC (µg/µg prot) Liver weight (%) 60 4 0.010 40 2 20 ### +/+ +/- -/- +/+ +/- -/- +/+ +/- -/- PPARa PPARa PPARa Liver PPARa mRNA levels (A), liver weight (B) and liver TC (C) were measured in PPARa+/+, PPARa+/- and PPARa-/-apoE2-KI mice. N=11 mice/group. Results are expressed as means  SE. NS=Non Significant. ##p<0.01, ### p<0.001 versus PPARa+/+ apoE2-KI mice.

  2. Supplemental figure II B A *** *** *** *** 180 180 CON CON 160 160 GW647 GW647 140 140 120 120 ### ### Relative LCAD mRNA expression Relative VLCAD mRNA expression 100 100 80 80 60 60 40 40 20 20 +/+ +/- -/- +/+ +/- -/- PPARa PPARa C D 140 # 140 * * CON CON ## 120 120 GW647 GW647 # 100 100 Relative MCP-1 mRNA expression Relative VCAM-1 mRNA expression 80 80 60 60 40 40 20 20 +/+ +/- -/- +/+ +/- -/- PPARa PPARa Primary hepatocytes were isolated from PPARa+/+, PPARa+/- and PPARa-/-apoE2-KI mice. A-B, Hepatocytes were in vitro treated with GW647 (600 nM) or vehicle (CON, 0.1% Me2SO) for 24h. C-D, Hepatocytes were in vitro treated with GW647 (600 nM) or vehicle (0.1% Me2SO) for 24h and stimulated with LPS (100 ng/mL) for an additional 6-h period. RNAs were extracted and subjected to quantitative RT-PCR analysis to measure VLCAD (A), LCAD (B), MCP-1 (C) and VCAM-1 (D) mRNA levels. *p<0.05, ***p<0.001 versus CON ; #p<0.05, ##p<0.01, ###p<0.001 versus GW647-treated PPARa+/+ apoE2-KI cells

More Related